1INN — innoscripta SE Balance Sheet
0.000.00%
Last trade - 00:00- €1.10bn
- €1.07bn
- €64.71m
- 44
- 10
- 67
- 30
Annual balance sheet for innoscripta SE, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | |
|---|---|---|
| Period Length: | — | — |
| Source: | ARS | ARS |
| Standards: | GAS | GAS |
| Status: | Final | Final |
| Cash and Equivalents | ||
| Cash and Short Term Investments | 13.7 | 23.9 |
| Net Total Accounts Receivable | ||
| Net Total Receivables | 19.5 | 31.6 |
| Total Inventory | ||
| Total Other Current Assets | ||
| Total Current Assets | 34.6 | 58.2 |
| Net Property, Plant And Equipment | 0.389 | 0.302 |
| Net Intangible Assets | ||
| Long Term Investments | ||
| Other Long Term Assets | ||
| Total Assets | 35.4 | 58.8 |
| Accounts Payable | ||
| Accrued Expenses | ||
| Notes Payable / Short Term Debt | ||
| Current Portion of Long Term Debt / Capital Leases | ||
| Total Other Current Liabilities | ||
| Total Current Liabilities | 3 | 5.79 |
| Long Term Debt | ||
| Total Long Term Debt | ||
| Total Debt | ||
| Total Other Liabilities | ||
| Total Liabilities | 17.3 | 23.7 |
| Common Stock | ||
| Retained Earnings (Accumulated Deficit) | ||
| Other Equity | ||
| Total Equity | 18.1 | 35.1 |
| Total Liabilities & Shareholders' Equity | 35.4 | 58.8 |
| Total Common Shares Outstanding |